Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice

Arthritis and Rheumatism

Volumn 65, Issue 7, 2013, Pages 1786-1794

  Toupet, Karine ^a   Maumus, Marie ^a   Peyrafitte, Julie Anne ^b   Bourin, Philippe ^b   Van Lent, Peter L E M ^c   Ferreira, Rosanna ^d   Orsetti, Béatrice ^a   Pirot, Nelly ^e   Casteilla, Louis ^f   Jorgensen, Christian ^a,d,g   Noël, Danièle ^a,h  

^a INSERM   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LAPEYRONIE HOSPITAL   (France)

^e INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^f Institut National de la Sant é et de la Recherche Medicale   (France)

^g CSA21   (France)

^h HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA1 INTEGRIN; ENDOGLIN; MICROSOMAL AMINOPEPTIDASE; THY 1 ANTIGEN; TRIACYLGLYCEROL;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALU SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTRAARTICULAR DRUG ADMINISTRATION; INTRAVENOUS ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENCHYMAL STEM CELL; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL NICHE; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; CELLS, CULTURED; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRA-ARTICULAR; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID;

EID: 84879850769     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37960     Document Type: Article

References (31)

1. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, et al. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010; 115: 1549-53.
2. Maumus M, Guerit D, Toupet K, Jorgensen C, Noel D,. Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res Ther 2011; 2: 14.
3. Li L, Jiang J,. Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms. Front Med 2011; 5: 33-9.
4. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54-63.
5. Saito T, Kuang JQ, Bittira B, Al-Khaldi A, Chiu RC,. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002; 74: 19-24.
6. Mouiseddine M, Francois S, Semont A, Sache A, Allenet B, Mathieu N, et al. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 2007; 80: S49-55.
7. Diekman BO, Wu CL, Louer CR, Furman BD, Huebner JL, Kraus VB, et al. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents post-traumatic arthritis. Cell Transplant 2012. E-pub ahead of print.
8. Ter Huurne M, Schelbergen R, Blattes R, Blom A, de Munter W, Grevers LC, et al. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum 2012; 64: 3604-13.
9. Bourin P, Peyrafitte JA, Fleury-Cappellesso S,. A first approach for the production of human adipose tissue-derived stromal cells for therapeutic use. Methods Mol Biol 2011; 702: 331-43.
10. Estes BT, Diekman BO, Gimble JM, Guilak F,. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 2010; 5: 1294-311.
11. Djouad F, Delorme B, Maurice M, Bony C, Apparailly F, Louis-Plence P, et al. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther 2007; 9: R33.
12. McBride C, Gaupp D, Phinney DG,. Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR. Cytotherapy 2003; 5: 7-18.
13. Monticello TM, Green DS, Yang H, Drain RL, Franco CT, Durham SK,. Spontaneous thymic lymphoma in severe combined immunodeficiency (SCID) mice engrafted with human peripheral blood lymphocytes. Vet Pathol 1994; 31: 393-5.
14. Walton M,. Degenerative joint disease in the mouse knee; histological observations. J Pathol 1977; 123: 109-22.
15. Nohroudi K, Arnhold S, Berhorn T, Addicks K, Hoehn M, Himmelreich U,. In vivo MRI stem cell tracking requires balancing of detection limit and cell viability. Cell Transplant 2010; 19: 431-41.
16. Schafer R, Ayturan M, Bantleon R, Kehlbach R, Siegel G, Pintaske J, et al. The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution. Cell Transplant 2008; 17: 923-41.
17. Kebriaei P, Robinson S,. Treatment of graft-versus-host-disease with mesenchymal stromal cells. Cytotherapy 2011; 13: 262-8.
18. Choi YH, Kurtz A, Stamm C,. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 2011; 22: 3-17.
19. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010; 62: 2467-75.
20. Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, et al. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 2007; 25: 220-7.
21. Kim DH, Je CM, Sin JY, Jung JS,. Effect of partial hepatectomy on in vivo engraftment after intravenous administration of human adipose tissue stromal cells in mouse. Microsurgery 2003; 23: 424-31.
22. Liao X, Li F, Wang X, Yanoso J, Niyibizi C,. Distribution of murine adipose-derived mesenchymal stem cells in vivo following transplantation in developing mice. Stem Cells Dev 2008; 17: 303-14.
23. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI,. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001; 169: 12-20.
24. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009; 18: 683-92.
25. Karystinou A, Dell'Accio F, Kurth TB, Wackerhage H, Khan IM, Archer CW, et al. Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology (Oxford) 2009; 48: 1057-64.
26. Djouad F, Bony C, Haupl T, Uze G, Lahlou N, Louis-Plence P, et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 2005; 7: R1304-15.
27. Kurth TB, Dell'Accio F, Crouch V, Augello A, Sharpe PT, De Bari C,. Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis Rheum 2011; 63: 1289-300.
28. + human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 2004; 103: 3313-9.
29. Allers C, Sierralta WD, Neubauer S, Rivera F, Minguell JJ, Conget PA,. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 2004; 78: 503-8.
30. Feng SW, Lu XL, Liu ZS, Zhang YN, Liu TY, Li JL, et al. Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice. Cytotherapy 2008; 10: 254-64.
31. Marinova-Mutafchieva L, Williams RO, Funa K, Maini RN, Zvaifler NJ,. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 2002; 46: 507-13.